| Q46353066 | Calcium signalling initiated by CR1 (CD35) crosslinking is mediated by phagocyte Fc gamma receptors in cis. |
| Q24336778 | Calcium-dependent neutrophil secretion: characterization and regulation by annexins |
| Q41974981 | Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils. |
| Q54672554 | Cdk5 variant 1 (cdk5-v1), but not full-length cdk5, is a centrosomal protein. |
| Q73748003 | Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain |
| Q47846757 | Cdk5/p35 expression in the mouse ovary. |
| Q40621457 | Cdk7 functions as a cdk5 activating kinase in brain. |
| Q84087883 | Clues for c-Yes involvement in the cell cycle and cytokinesis |
| Q48491972 | Controversies over p25 in Alzheimer's disease. |
| Q47173164 | Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. |
| Q44720660 | Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. |
| Q48158450 | Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. |
| Q37343521 | Enhancement of Peripheral Nerve Regrowth by the Purine Nucleoside Analog and Cell Cycle Inhibitor, Roscovitine. |
| Q36602864 | Extraneuronal roles of cyclin-dependent kinase 5. |
| Q46089592 | GTP-dependent permeabilized neutrophil secretion requires a freely diffusible cytosolic protein. |
| Q45112981 | GTP-dependent secretion from neutrophils is regulated by Cdk5. |
| Q38709044 | Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia |
| Q92022584 | HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway |
| Q42219681 | Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker. |
| Q49161768 | Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain. |
| Q42357502 | Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients |
| Q53306742 | Localization of CDK5 in the midbody and increased aneuploidy in CDK5-/- cells. |
| Q48215901 | Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore. |
| Q55333937 | Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion. |
| Q42738418 | Novel alternatively spliced variant form of human CDK5RAP2. |
| Q35048652 | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells. |
| Q80971284 | ODF1 phosphorylation by Cdk5/p35 enhances ODF1-OIP1 interaction |
| Q48160993 | Outer dense fibers serve as a functional target for Cdk5.p35 in the developing sperm tail. |
| Q46737449 | Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells. |
| Q73983995 | Purification of dual-tagged intact recombinant proteins |
| Q92887290 | ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals |
| Q35835884 | Species-Specific Expression of Full-Length and Alternatively Spliced Variant Forms of CDK5RAP2. |
| Q90407361 | Targeting Cdk5 for killing of breast cancer cells via perturbation of redox homeostasis |
| Q44406443 | The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum. |
| Q53347855 | The primary microcephaly 3 (MCPH3) interacting protein, p35 and its catalytic subunit, Cdk5, are centrosomal proteins. |
| Q35213131 | Thrombin enhances NGF-mediated neurite extension via increased and sustained activation of p44/42 MAPK and p38 MAPK. |
| Q38021272 | Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation. |